Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis-Reference-Cited by-同舟云学术

Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis

Published:2010-10 Issue:4 Volume:139 Page:1198-1206
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Manns Michael P.,Woynarowski Marek,Kreisel Wolfgang,Lurie Yoav,Rust Christian,Zuckerman Elimelech,Bahr Matthias J.,Günther Rainer,Hultcrantz Rolf W.,Spengler Ulrich,Lohse Ansgar W.,Szalay Ferenc,Färkkilä Martti,Pröls Markus,Strassburg Christian P.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Classification of chronic hepatitis: diagnosis, grading and staging;Desmet;Hepatology,1994

2. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis;Soloway;Gastroenterology,1972

3. Controlled trial of prednisone and azathioprine in active chronic hepatitis;Murray-Lyon;Lancet,1973

4. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis;Kirk;Gut,1980

5. Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis;Czaja;Gastroenterology,2010

Cited by 364 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal and hepatic manifestations;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort;JHEP Reports;2024-09

3. Budesonide in Liver Immunology: A Therapeutic Opportunity in Liver Transplantation;Current Transplantation Reports;2024-07-11

4. Reply to: Comments on “An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis”;Journal of Hepatology;2024-07

5. Should MMF treatment be the first-line therapy in autoimmune hepatitis?;Journal of Hepatology;2024-07